FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to therapy of infectious diseases, and can be used for treating Covid-19. Method includes inhalations of a Lidocaine solution 20 mg/ml 4 ml using a compression nebuliser 4 to 6 times a day for 5 to 10 days, tablets: Famotidine 40 mg 3 to 4 times a day for 7 to 14 days, Doxycycline 100 mg 3 times a day for 7 to 10 days, Bromhexine 8 mg 4 times a day for 7 to 14 days, Spironolactone 50 mg 1 time a day for 7 to 14 days, Nifuroxazide 200 mg 4 times a day for 7 days. Intramuscular injections of a solution of Unithiol or Dimercaprol 50 mg/ml 10 ml are also performed according to the following plan: days 1 to 2 — 10 ml 4 times a day, days 3 to 4 — 10 ml 3 times a day, days 5 to 7 — 10 ml 2 times a day.
EFFECT: possibility of suppressing the spread of the virus in the body by means of the comprehensive effect of the medical products on the factors of pathogenesis, in particular, the inhibition of matrix metalloproteinases, phospholipase A2, and proteases.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING COVID-19 | 2021 |
|
RU2777645C1 |
METHOD OF TREATING PATIENTS WITH SUBSIDING OR SUBSIDED THROMBOPHLEBITIS OF SAPHENOUS VEINS OF LOWER EXTREMITIES AFTER SUFFERING CORONAVIRUS INFECTION COVID-19 | 2024 |
|
RU2825065C1 |
METHOD OF TREATING COVID-19 IN CHILDREN AT RISK OF SEVERE CLINICAL COURSE OF DISEASE | 2023 |
|
RU2815303C1 |
METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
METHOD FOR CHOOSING MANAGEMENT TACTICS FOR PATIENTS AFTER CORONAVIRUS INFECTION COVID-19 IN ORDER TO PREVENT LONG-TERM THROMBOTIC COMPLICATIONS | 2021 |
|
RU2770356C1 |
METHOD OF TREATING FOCAL AND CAVITARY CHANGES IN LUNGS OF POST-COVID ETIOLOGY | 2023 |
|
RU2809304C1 |
TECHNOLOGY OF REHABILITATION-PREVENTIVE NUTRITIONAL SUPPORT IN CORONAVIRUS INFECTION | 2020 |
|
RU2735723C1 |
METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
METHOD FOR IMPROVING OXYGENATING PULMONARY FUNCTION IN THE PATIENTS WITH A NEW CORONAVIRAL INFECTION (COVID-19) WITH RESPIRATORY FAILURE WHO ARE ON RESPIRATORY SUPPORT | 2020 |
|
RU2735797C1 |
METHOD FOR THE TREATMENT OF THROMBOCYTOPENIA IN CORONAVIRUS INFECTION | 2022 |
|
RU2783888C1 |
Authors
Dates
2023-01-19—Published
2021-10-18—Filed